Asterias stem cell therapy shows promise in spinal cord paralysis, study says – Fox News
Fox News |
Asterias stem cell therapy shows promise in spinal cord paralysis, study says
Fox News NEW YORK – An experimental stem cell therapy developed by Asterias Biotherapeutics restored some movement to patients paralyzed by recent spinal cord injuries, according to interim data from a small study being presented on Wednesday. One of the five … Asterias Stem Cell Therapy Helps Paralyzed People in Small StudyBloomberg What We’re Looking For From The Upcoming Asterias Biotherapeutics Inc (NYSEMKT:AST) PresentationStreet Register |
The Express Tribune |
Asterias stem cell therapy shows promise in spinal cord paralysis: US st…
Reuters The company had not expected to reach the efficacy goal before six to 12 months after implantation of the 10 million embryonic stem cells dubbed AST-OPC1, Asterias Chief Executive Stephen Cartt said. “We came out early with the data because it was so … What We’re Looking For From The Upcoming Asterias Biotherapeutics Inc (NYSEMKT:AST) PresentationStreet Register |
The Express Tribune |
Asterias stem cell therapy shows promise in spinal cord paralysis: US st…
Reuters The company had not expected to reach the efficacy goal before six to 12 months after implantation of the 10 million embryonic stem cells dubbed AST-OPC1, Asterias Chief Executive Stephen Cartt said. “We came out early with the data because it was so … Asterias Stem Cell Therapy Helps Paralyzed People in Small StudyBloomberg What We’re Looking For From The Upcoming Asterias Biotherapeutics Inc (NYSEMKT:AST) PresentationStreet Register |
The Express Tribune |
Asterias stem cell therapy shows promise in spinal cord paralysis -U.S. study
Thomson Reuters Foundation NEW YORK, Sept 14 (Reuters) – An experimental stem cell therapy developed by Asterias Biotherapeutics restored some movement to patients paralyzed by recent spinal cord injuries, according to interim data from a small study being presented on … What We’re Looking For From The Upcoming Asterias Biotherapeutics Inc (NYSEMKT:AST) PresentationStreet Register |
